Semaglutide Research
Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial
Schizophrenia Research·May 1, 2026
Christoph U. Correll, et al.
Summary
Secondary analysis showing improved quality of life with semaglutide treatment in patients with schizophrenia.
Study Details
Study Design
Secondary analysis of randomized controlled trial
Indication
Schizophrenia spectrum disorder with obesity
Intervention
Semaglutide vs placebo
Species
Human